SEC Form 4 · accession 0000947871-15-000566
WebMD Health Corp. · WBMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley S Trotman Jr.
Director
Period of report
Aug 17, 2015
Accepted (ET)
Aug 18, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | M | 6,600 | $14.34 | A | 34,420 | D | |
| Common StockF1 | Aug 17, 2015 | S | 6,600 | $42.83 | D | 27,820 | D | |
| Common StockF2 | Aug 17, 2015 | S | 1,325 | $42.76 | D | 26,495 | D | |
| Common Stock | holding | — | — | — | 935 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $14.34 | Aug 17, 2015 | M | 6,600 | D | — | Jan 1, 2023 | Common Stock | 6,600 | 6,600 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.66 to $43.11 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.66 to $42.96 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F325% of the grant that included these options vested on each of January 1, 2014 and January 1, 2015 and 25% of such grant will vest on each of January 1, 2016 and January 1, 2017.